Commonwealth Equity Services
CSBR icon

Commonwealth Equity Services’s Champions Oncology CSBR Stock Holding History

Commonwealth Equity Services’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-11,910
Closed -$76K – 2806
2018
Q2 		$76K Buy
+11,910
New +$57.3K ﹤0.01% 2628
2017
Q4 		– Sell
-16,767
Closed -$62K – 2686
2017
Q3 		$62K Sell
16,767
-3,693
-18% -$11.3K ﹤0.01% 2456
2017
Q2 		$53K Buy
20,460
+3,807
+23% +$9.94K ﹤0.01% 2415
2017
Q1 		$53K Buy
+16,653
New +$58.3K ﹤0.01% 2320

Other funds holding CSBR

BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Commonwealth Equity Services's CSBR Position: Q3 2018 in Review

Commonwealth Equity Services sold out of Champions Oncology (CSBR) in Q3 2018, closing a stake of 11,910 shares — an estimated $76K sold.

Commonwealth Equity Services first reported a position in CSBR in Q1 2017 and held it in 4 quarters. The position peaked at $76K in Q2 2018. 37 funds tracked by Wall St. Rank hold CSBR as of Q3 2018.

  • Commonwealth Equity Services reported no remaining Champions Oncology position as of Q3 2018 after selling out during the quarter.
  • Commonwealth Equity Services sold 11,910 Champions Oncology shares in Q3 2018, an estimated $76K.
  • Commonwealth Equity Services first reported a position in Champions Oncology in Q1 2017 and held it in 4 quarters.
  • Commonwealth Equity Services's Champions Oncology position peaked at $76K in Q2 2018.
  • 37 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2018.

Based on Commonwealth Equity Services's 13F filing for Q3 2018, filed 6 Nov 2018.